Platinum Investment Management Ltd. Takes $1.60 Million Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Platinum Investment Management Ltd. purchased a new stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 19,138 shares of the biopharmaceutical company’s stock, valued at approximately $1,598,000. Several other hedge funds have also made changes to their positions in the company. Seven Eight Capital LP purchased […]

Related Keywords

United States ,America ,Robert Arthur Harrington ,Fady Ibraham Malik ,Raymond James ,Rafferty Asset Management ,Cytokinetics Company Profile ,Platinum Investment Management Ltd ,Cytokinetics Incorporated ,Asset Management Inc ,Platinum Investment Management ,Free Report ,Eight Capital ,Point Capital ,Hill Management Partners ,Asset Management ,Management Inc ,Ibraham Malik ,Director Robert Arthur Harrington ,Get Free Report ,Visit Holdingschannel ,Cytokinetics Daily ,